You can now access your Information Kit electronically, and learn about what's possible with STELARA®.
You will also receive an e-mail within the next 24 hours that contains a link to your E-kit. Click on the link to build and read your E-kit at your convenience.
To ensure you receive timely information about STELARA® and plaque psoriasis, please add email@example.com to your e-mail address book. In the meantime, explore our website to learn more about STELARA® and start taking advantage of all the resources available to you.
Our Instant Savings Program can help lower your out-of-pocket costs including co-pay, deductible, and co-insurance medication costs. If you qualify, your out-of-pocket costs will be $10 for each dose up to the maximum annual program benefit of $10,000, 6 doses, or 12 months from the card activation date, whichever comes first.
You may be eligible for Instant Savings if you have been given STELARA® by your doctor, are being treated for the FDA-approved use for STELARA®, and currently have commercial insurance that covers medication costs for STELARA®. A Care Coordinator can provide you with more details and see if you are able to participate.
If you do not have prescription coverage for STELARA®, Janssen Prescription Assistance may be able to help. Janssen Prescription Assistance contains information about prescription assistance programs sponsored by relevant Janssen Pharmaceutical Companies as well as up-to-date information about independent foundations that may have available funding to help minimize drug costs for STELARA®. More information is available at JanssenPrescriptionAssistance.com/stelara-cost-assistance.
If you have Medicaid, Medicare, or other insurance and still cannot afford STELARA®, we can direct you to independent foundations that may be able to help you.
STELARA® is a prescription medicine approved to treat adults 18 years and older with moderate or
severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).
STELARA® is a prescription medicine approved to treat adults 18 years and older with active psoriatic arthritis, either alone or with methotrexate.
STELARA® is a 45 mg or 90 mg injection given under the skin as directed by your doctor at weeks 0, 4, and every 12 weeks thereafter. It is administered by a healthcare provider or self-injected only after proper training.
STELARA® is a prescription medicineA drug that is only available with written instructions from a healthcare professional to a pharmacist. that affects your immune system. STELARA® can increase your chance of having serious side effects including:
STELARA® may lower your ability to fight infections and may increase your risk of infections. While taking STELARA®, some people have serious infections, which may require hospitalization, including tuberculosis (TB)An infectious disease, most commonly of the lungs, resulting in coughing, fever, chest pain, and weight loss., and infections caused by bacteria, fungi, or virusesGerms that grow within the body and cause a disease..
STELARA® may decrease the activity of your immune systemA system inside the body that protects against germs and infections. and increase your risk for certain types of cancer. Tell your doctor if you have ever had any type of cancer. Some people who had risk factors for skin cancer developed certain types of skin cancers while receiving STELARA®. Tell your doctor if you have any new skin growths.
RPLS is a rare condition that affects the brain and can cause death. The cause of RPLS is not known. If RPLS is found early and treated, most people recover. Tell your doctor right away if you have any new or worsening medical problems including: headache, seizures, confusion, and vision problems.
Serious allergic reactions can occur. Get medical help right away if you have any symptoms such as: feeling faint, swelling of your face, eyelids, tongue, or throat, trouble breathing, throat or chest tightness, or skin rash.
© Janssen Biotech, Inc. 2013
This site is published by Janssen Biotech Inc., which is solely responsible for its contents. The material on this site is intended only as informational or as an educational aid and is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.
The information on this site is intended for the use of patients and caregivers in the United States and Puerto Rico only. Laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States and Puerto Rico.
Last updated April 01, 2014.